MAY 9 - 10 2018 Opens: 6:00 AM PT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Genetics and Genomics 2018
11 7 1053

As the foundation of life, genetics provides a base for other sciences to grow from. This is why LabRoots is excited to announce the 6th Annual Genetics and Genomics virtual conference! The free, two-day Genetics and Genomics 2018 event will cover the most recent and exciting advances in genetics research.
 

LabRoots invites research scientists, post docs, principal investigators, lab directors and other genetics professionals to learn about new discoveries and discuss their own findings with like-minded colleagues and experts in the field. Some topics of discussion from Genetics 2017 included: gene therapy, gene modifiers and disease progression, single cell genomics, liquid biopsies and exosome, and precision medicine.
 

Genetics and Genomics conference participants benefit from interacting with field experts and networking with colleagues. Attendees can also “walk” through the virtual exhibit hall to learn about the latest in genetics and genomics tools and assays. Join LabRoots in leading progress toward understanding the genetics behind disease and treatment!
 

Our virtual conference allows you to participate in a global setting with no travel or cost to you. You can participate in exactly those parts which you are interested in and be back at your desk or bench in an instant. Virtual events remove time and place restrictions and ensure that everyone who wants to participate can do so. This virtual conference also offers increased reach for the global genetics community with a high degree of interaction through live-streaming video and chat sessions.
 

Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2018 Genetics and Genomics Virtual Event. Submission is free. Submit your abstract here
 

Continuing Education
By participating in this virtual event and watching webcast presentations, you can earn free CEU, PACE, and/or CME credits. To earn educational credits, you must view an entire presentation. Following the presentation, you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit. The American Board of Genetic Counseling, certifies genetic counselors and accredits genetic counseling training programs. The National Society of Genetic Counselors (NSGC) is the professional membership association for the genetic counseling profession.
 

Use #LRgenetics to follow the conversation!


Speakers:
  • Associate Director for Population Sciences, Professor of Community and Family Medicine at the Geisel School of Medicine, Norris Cotton Cancer Center, Dartmouth College
  • Head, Kinghorn Centre for Clinical Genomics, Garvan Institute; CEO, Genome.One
  • Professor, Computer Science and AI Lab, Director, MIT Computational Biology Group, Broad Institute of MIT and Harvard
  • Chief Scientific Officer, Pacific Biosciences
  • Research Fellow, Dana-Farber Cancer Institute
  • Lead Scientific Programmer, Baylor College of Medicine
  • Assistant Professor Department of Molecular Virology, Immunology and Medical Genetics, Assistant Professor, Division of Hematology, Department of Internal Medicine, Human Cancer Genetics Prog

Show Resources
Posters

POSTER SUBMISSION GUIDELINES

Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.

SUBMIT YOUR ABSTRACT

Enter the following information to this Submission Form:

  • Poster Title
  • Your Name
  • Your Institution
  • Your Email
  • Abstract describing the poster

All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

Questions? Email Posters@LabRoots.com

LabRoots Policy

Agenda
All times are Pacific Time
Speakers

  • Christopher I Amos, PhD
    Associate Director for Population Sciences, Professor of Community and Family Medicine at the Geisel School of Medicine, Norris Cotton Cancer Center, Dartmouth College
    Biography
      Dr. Christopher Amos received his M.S. and Ph.D. degrees in 1985 and 1988 from the Louisiana State University Medical Center in New Orleans from the Department of Biometry and Genetics. In his graduate studies he developed novel approaches for conducting genetic linkage analysis for multivariate data and in extended families. Subsequently, Dr. Amos completed training in Medical Genetics through the Inter-institute training program in Genetics at the NIH (1992), where he also completed postdoctoral training in the Family Studies Section of the Environmental Epidemiology Branch at the National Cancer Institute. During this period (1988-1992), he studied inheritance patterns of breast and ovarian cancers, publishing seminal papers in the Journal of the American Medical Association and the Journal of the National Cancer Institute. He also developed a novel and widely cited approach for linkage analysis that was published in the American Journal of Human Genetics in 1994(PMID:8116623, 787 citations). He has authored or coauthored 548 peer reviewed papers, 19 reviews or book chapters, 2 books and has an H index of 104 with 43,170 citations. His work is funded by 11 current and 2 approved pending P01 grants from NIH (on one he serves as communicating PI). He has served as PI, multiple PI or core leader on 25 funded grants (including R01, U01, P01, U19, P20, P30 and T32 grants from NIH and ACS grants) and coinvestgator on an additional than 14 grants. In 1992 he was recruited to the M.D. Anderson Cancer Center where he joined the Department of Epidemiology and established the Section of Computational and Genetic Epidemiology. There he developed and applied novel bioinformatical approaches for identifying genomic factors influencing lung, breast, head and neck, colon and brain cancer development. In 1994 he received his first NIH R01 to develop model-free linkage analysis methods and develop software to support these methods. He has subsequently received several other NIH grants as PI as well as Co-Investigator that have supported the development of new statistical methods to understand the interplay of genetic and environmental factors that cause lung cancer development. He wrote a book 'Forward-Time Population Genetics Simulations: Methods, Implementation, and Applications') with coauthors Dr. Bo Peng (at M.D. Anderson Cancer Center) and Dr. Marek Kimmel (at Rice) that describes approaches to simulating populations for genetic analyses. He also led studies that recruited and studied individuals with inherited risk for lung, colon and breast cancer. In 2004, in collaboration with Dr. Joan Bailey-Wilson and others, he identified a region of chromosome 6q23-25 that harbors a locus greatly increasing lung cancer risk, and showed in 2010 that this locus identifies individuals exquisitely sensitive to tobacco smoke. This collaboration led to the discovery that mutations in Park2 increase lung cancer risk. In 2008, he led large genetic studies that identified common variants in CHRNA5 (PMID 20554942 cited 1032 times) that have substantial impact on both lung cancer risk and smoking behavior, making it more difficult for smokers to quit. Dr. Amos led an ACS funded grant to study Peutz-Jeghers syndrome a rare condition that causes greatly increased risk for breast, colon and pancreatic cancers with most cases carrying mutations in STK11. He also lead the biostatistics and bioinformatics core for Dr. Louise Strong's P01 'A mutational model for Childhood Cancers' which led to the development of novel approaches for statistical and bioinformatical analysis to identify modifiers of risk for cancer. He also led several other bioinformatical and supported database development for several large projects including the Human Pedigree Analysis Resource core of the M.D. Anderson Cancer Center Support Grant, database development for the Gliogene Consortium, led by Dr. Melissa Bondy to identify genetic factors for familial brain cancers and Bioinformatics leader for the Texas Cancer Genetics Consortium which brought together investigators from UT Southwestern, UT San Antonio, UT M.D. Anderson Cancer Center and the Baylor College of Medicine to identify high risk families with cancer for whom targeted prevention and interventions would be effective. In 2012, Dr. Amos moved to the Geisel School of Medicine at Dartmouth College where he became the inaugural Chair for the Department of Biomedical Data Science, which includes Divisions of Biostatistics, Biomedical Informatics and Behavioral Studies. The Department grew under his leadership to 24 faculty members and about 80 staff. He also heads the Center of Genomic Medicine and became the Norris Cotton Cancer Center's Associate Director for Population Studies. Dr. Amos continued the work to identify and characterize genetic factors influencing lung cancer risk. He led an international team that studied over 50,000 individuals and identified uncommon mutations in BRCA2 that confer a 250% higher risk for developing squamous lung cancer. Dr. Amos is leading an international collaboration entitled 'Transdisciplinary Research in Cancer of the Lung' that had been supported by a U19 award from the NCI, which integrates genetic studies from international sites for discovery and epidemiological analysis of lung cancer risk. Work being performed by this consortium has been organized into a P01 submission that recently was approved for funding at the NCI with an expected start date of June 1, 2017. Dr. Amos moved to the Baylor College of Medicine on November 1, 2017 where he is the Associate Director for Quantitative Research and the Director of the Institute for Clinical and Translational Research. In addition to lung cancer, Dr. Amos has been involved in cutting edge research in other malignancies. He led the OncoArray Consortium that recently completed genotyping of about 500,000 individuals using a customized array developed with Illumina that comprises 500,000 markers. It was developed to decipher the genetic architecture of common cancers including prostate, colon, breast and ovarian cancers. Managing population-based analysis of this very large study required the development of new analytical approaches for characterizing the ethnic origin of participants to avoid confounding and the approach (published in BMC Bioinformatics). Results of studies using this array have been published in Nature Genetics for Head and Neck, Glioma (led by Dr. Melissa Bondy at the Baylor College of Medicine), and Ovarian Cancer, and there are additional accepted papers forthcoming in Nature and Nature Genetics. These papers have revealed the genetic architectures and more novel variants influencing Lung cancer, and ER+ and ER- breast cancer. Since 2014, Dr. Amos has been collaborating with Drs. Hashem El-Serag at Baylor College of Medicine and Manal Hassan at the M.D. Anderson Cancer Center in the Hepatobiliary Cancer Consortium which brings together North American Investigators to understand its environmental and genetic etiologies. This research has established a national consortium to identify genetic and environmental factors contributing to the epidemic of hepatobiliary cancer. Dr. Amos leads the design and analytical team responsibilities for the consortium. At Dartmouth, Dr. Amos co-leads the New Hampshire Colonoscopy Registry. Currently, he is serving at the interim Director of the Norris Cotton Cancer Center (NCCC), an NCI-designated cancer center. He leads the Center for Genomic Medicine, which was developed in collaboration with leaders in Pathology to develop approaches for routine sequencing for cancer NCCC patients. These data have been integrated with the electronic medical record, and are being used to identify clinical characteristics of patients associated with carriage of actionable mutations. Dr. Amos is also leader in cancer research mentoring. He is director of a Center of Biomedical Research Excellence grant (P20) 'Quantitative Biomedical Research Institute' that mentors junior faculty toward their initial award of an R01, and supports bioinformatics and personalized medicine at Dartmouth College and surrounding institutions in New Hampshire, Maine and Vermont. Dr. Amos serves as leader of the Biostatistics Epidemiology and Research Design component of the Clinical and Translational Institute at Dartmouth College, and has been directing the biomedical informatics team. Finally, Dr. Amos is leading a T32 training grant funded by the Knowledge to Big Data initiative for training graduate students in biomedical data sciences. Dr. Amos's expertise is recognized nationally and internationally. Dr. Amos became the President of the International Genetic Epidemiology Society in 2002, and served as its Secretary/Treasurer from 2007 to 2012. He served on the board of external scientific advisors for the Centre Etude Polymorphism Humain from 2007-2014. He was elected as a fellow of the American Association for the Advancement of Science in 2012. He currently serves on the Board of Scientific Counselors for the National Institute of Environmental Health Sciences. He completed a term as reviewer for the Access Committee for the Center for Inherited Disease Research from 2007-2011. He has also served as a reviewer for NIH, Cancer Research UK, and Canadian Institute for Health Research and numerous other panels. He has served or is serving as an associate editor for the American Journal of Human Genetics, Genes and Immunity, Genetic Epidemiology and Human and Molecular Genetics, and as a statistical editor for the Journal of the National Cancer Institute.
    • Marcel Dinger, PhD
      Head, Kinghorn Centre for Clinical Genomics, Garvan Institute; CEO, Genome.One
      Biography
        Marcel Dinger is the Founding CEO of Genome.One, Head of the Kinghorn Centre for Clinical Genomics (KCCG) at the Garvan Institute of Medical Research and conjoint Associate Professor at UNSW Australia. Genome.One is a world-class clinical genomics service and develops specialist software and analytics solutions to enable precision healthcare worldwide. Genome.One was one of the first companies in the world to implement the HiSeq X Ten genome sequencing platform, which has capacity to sequence 18,000 human genomes per year, and provide a disease diagnostics service based on whole genome sequencing. He has worked in bioinformatics and genomics since 1998 in both commercial and academic capacities. He was awarded his PhD in 2003 from the University of Waikato in New Zealand, has published >90 papers attracting more than 10,000 citations, and is recipient of several highly competitive awards and fellowships. He is also a founder of two other successful start-up companies. In 2016, Marcel was admitted as a Fellow into the Faculty of Sciences of the Royal College of Pathologists of Australiasia and is a Graduate of the Australian Institute of Company Directors.
      • Manolis Kellis, PhD
        Professor, Computer Science and AI Lab, Director, MIT Computational Biology Group, Broad Institute of MIT and Harvard
        Biography
          Manolis Kellis is a Professor of Computer Science at MIT, where he directs the MIT Computational Biology Group (compbio.mit.edu). He has helped direct several large-scale genomics projects, including the NIH Roadmap Epigenomics project, the comparative analysis of 29 mammals, the Encyclopedia of DNA Elements (ENCODE) project, and the Genotype Tissue-Expression (GTEx) project. He received the US Presidential Early Career Award in Science and Engineering (PECASE), the NSF CAREER award, the Alfred P. Sloan Fellowship. He obtained his Ph.D. from MIT, where he received the Sprowls award for the best doctorate thesis in computer science. He lived in Greece and France before moving to the US.
        • Jonas Korlach, PhD
          Chief Scientific Officer, Pacific Biosciences
          Biography
            Jonas Korlach was appointed Chief Scientific Officer of Pacific Biosciences in July 2012. He was previously a Scientific Fellow, supporting commercial development of the PacBio RS II system and performing research aimed at developing new applications for SMRT technologies. He co-invented the SMRT technology with Stephen Turner, Ph.D., Pacific Biosciences Founder and Chief Technology Officer, when the two were graduate students at Cornell University. Dr. Korlach joined Pacific Biosciences as the company's eighth employee in 2004. Previously, he was a Postdoctoral Researcher at Cornell University. Dr. Korlach is the recipient of multiple grants, an inventor on 70 issued U.S. patents and 61 international patents, and an author of over 70 scientific studies on the principles and applications of SMRT technology, including publications in Nature, Science, and PNAS. In 2013, Dr. Korlach was honored by the Obama White House as an Immigrant Innovator "Champion of Change." He received both his Ph.D. and his M.S. degrees in Biochemistry, Molecular and Cell Biology from Cornell, and received M.S. and B.A. degrees in Biological Sciences from Humboldt University in Berlin, Germany.
          • Joseph Paulson, PhD
            Research Fellow, Dana-Farber Cancer Institute
            Biography
              I am a Research Fellow in the Department of Biostatistics and Computational Biology at the Dana-Farber Cancer Institute and Department of Biostatistics at the Harvard TH Chan School of Public Health under the guidance of Professor John Quackenbush. Prior to joining Harvard I was a National Science Foundation Graduate Research Fellow at the University of Maryland, College Park where I received my Ph.D. in Applied Mathematics, Statistics and Scientific Computation. As a computer scientist and computational biologist, my interests are to develop computational methods for the analysis of high-throughput sequencing data. I also desire to develop software and support these methods as open-source software for the broader scientific community through Bioconductor and popular domain tools such as QIIME and Phyloseq. MetagenomeSeq, is my most popular tool developed and is in the top 5% of all Bioconductor packages downloaded in the last year with over 5,000 unique users. I am excited to leverage statistical and network methodologies in accounting for technological when identifying disease markers.
            • Fritz Sedlazeck, PhD
              Lead Scientific Programmer, Baylor College of Medicine
              Biography
                Dr. Fritz Sedlazeck completed his PhD in 2012 in the group of Dr. Arndt von Haeseler at the Max F. Perutz Laboratory in Vienna. After a two year postdoc, he transitioned to the lab of Dr. Michael Schatz at Cold Spring Harbor Laboratory and later to Johns Hopkins University. Since 2017 he leads his own group at the Human Genome Sequencing Centre at Baylor College of Medicine. His research focuses on developing computational methods to detect and analyse genomic variations with a focus on Structural Variations. Structural Variations are genomic events that manipulate multiple positions in a genome, which impact evolution, genomic disorders, regulation as well as play an important role in explaining multiple phenotypes.
              • David E Symer, MD, PhD
                Assistant Professor Department of Molecular Virology, Immunology and Medical Genetics, Assistant Professor, Division of Hematology, Department of Internal Medicine, Human Cancer Genetics Prog
                Biography
                  Dr. David Symer is an assistant professor in the Human Cancer Genetics Program, Department of Molecular Virology, Immunology and Medical Genetics and Department of Internal Medicine, Division of Hematology at the Ohio State University Comprehensive Cancer Center James Cancer Hospital. Recently, Dr. Symer also was named interim director of the core laboratory offering shared resources in genomics at Ohio State, the Nucleic Acids / Microarray Shared Resource. Dr. Symer has ongoing research interests in molecular biology and in cancer genetics and genomics. His primary clinical interest is chronic lymphocytic leukemia. He graduated with an AB degree in mathematics from Dartmouth College, earned his MD and PhD degrees at Johns Hopkins University School of Medicine, did his residency at Brigham and Womens Hospital (Harvard Medical School), and completed his fellowship training at Brigham and Womens Hospital and Johns Hopkins Oncology Center. Dr. Symer was a principal investigator at the National Cancer Institute prior to moving to Ohio State in 2009. <br />
                Sponsored By

                For information on becoming a sponsor or exhibitor, please click here.


                Committee

                To download the Program Committee brochure here.


                • Timothy Harris, PhD

                  Since June 2011, Dr. Harris has served as the Senior Vice President of Translational Medicine at Biogen Idec. Dr. Harris has served as the Director of the Advanced Technology Program at SAIC Frederick since 2007 and Chief Technology Officer for SAIC Frederick since 2008. Prior to ...

                  See more See less
                • Agnieszka Lichanzka Ph.D.

                  Agnieszka is currently a Staff Scientist and Laboratory Manager at TessArae, LLC in Sterling, VA, USA. She obtained her PhD at the University of Queensland in Australia in a field of biochemistry, and subsequently worked as a post-doctoral fellow at Queen's University of Belfast ...

                  See more See less
                • Charles Cantor, PhD

                  Dr. Charles Cantor is a founder, and Chief Scientific Officer at SEQUENOM, Inc., which is a genetics discovery company with tools, information and strategies for determining the medical impact of genes and genetic variations. He is also the founder of SelectX Pharmaceuticals ...

                  See more See less
                • Deanne Taylor, MS, PhD

                  Dr. Taylors background is in biophysics, bioinformatics, computational biology and structural biology with emphasis on human genetics and translational medicine. She obtained her Ph.D. in Biophysics from the University of Michigan, Ann Arbor, and completed a postdoctoral ...

                  See more See less
                • C Jimmy Lin, MD, PhD, MHS

                  Jimmy Lin, MD, PhD, MHS, is a 2012 TED Fellow and Founder & President of Rare Genomics Institute, the world's first platform to enable any community to leverage cutting-edge biotechnology to advance understanding of any rare disease. Partnering with 18 of the top medical ...

                  See more See less
                • John Quackenbush, PhD

                  John Quackenbush received his PhD in 1990 in theoretical physics from UCLA working on string theory models. Following two years as a postdoctoral fellow in physics, Dr. Quackenbush applied for and received a Special Emphasis Research Career Award from the National Center for ...

                  See more See less
                • Pierre-Antoine Gourraud, PhD, MPH

                  Pierre-Antoine Gourraud is a former student of the Ecole Normale Suprieure de Lyon in France. After receiving an M.P.H. from University Paris XIII in 2002, he got his Ph.D. in Immunogenetic Epidemiology and Public Health from Toulouse University in 2005. He relocated to the ...

                  See more See less
                • Shawn Baker, PhD

                  Dr. Shawn C. Baker is the Chief Science Officer and co-founder of AllSeq. Having received his Ph.D. at the University of California - Davis, he started his career as a Research Scientist at Illumina when it was a 15-person startup. After spending several years at the bench ...

                  See more See less
                • Vincent Mauro, Ph.D.

                  Dr. Mauro is an Associate Professor in the Department of Neurobiology at the Scripps Research Institute in La Jolla, California. He is also a co-founder and lead scientist of Promosome, a biotechnology company focused on bioproduction enablement and DNA vaccines. In addition, Dr ...

                  See more See less
                • Yue Wan, PhD

                  Yue Wan received her B.Sc in Cell Biology and Biochemistry from the University of California, San Diego. She obtained her Ph.D in Cancer Biology Stanford University, California, USA, under the mentorship of Howard Y. Chang. During her PhD, she developed the first ...

                  See more See less
                Help

                General LabRoots Questions

                For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                Contact us

                Virtual Events and Webinars

                Supported Configurations

                • Operating System Internet Explorer Firefox Chrome Safari
                  Vista IE8+ FF10+ Chrome15+
                  Windows 7 IE8+ FF10+ Chrome15+
                  Windows 8 IE10 FF10+ Chrome15+
                  Mac OS X   FF10+ Chrome15+ Safari5.1+
                • Cookie settings: session cookies enabled
                • Browser configuration must have JavaScript enabled
                • Adobe Flash player 10.2 or later

                To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                Internet Connection

                • A minimum of 100Kbps is recommended for audio-only events
                • A minimum of 300Kbps is recommended for speaker on-video events

                Computer Equipment

                • Screen Resolution: Minimum 1024x768
                • Video Card: 65,000 colors minimum
                • Sound card and speakers (or headphones) for hearing webcast in full format
                • Audio Card: 16-bit minimum
                • RAM: 512MB of free RAM

                Firewall Protocol

                • HTTP on port 80 or HTTPS on port 443
                • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                Work-At-Home Attendees

                • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                For A Seamless Experience

                When using a mobile device, FREE Mobile Apps are available:

                - For viewing Webinars:

                - For viewing Virtual Events

                Attendee Guide

                • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                Virtual Event and Webinar Support:

                Continuing Education (CME/CE) Support

                Loading Comments...
                Show Resources
                Event Countdown
                • 0 Days
                • 0 Hours
                • 0 Minutes
                • 0 Seconds